跳至主要内容
临床试验/NCT04514042
NCT04514042Unknown不适用

Comparison of Zenker's Diverticulum Treatment Using Peroral Endoscopic Myotomy and Flexible Endoscopy Septotomy: International, Multicentre, Randomized, Double-blind Clinical Trial.

Maria Sklodowska-Curie National Research Institute of Oncology1 个研究点 分布在 1 个国家目标入组 165 人开始时间: 2020年10月最近更新:
适应症

试验速览

阶段
不适用
入组人数
165
试验地点
1
主要终点
Rate of short-term clinical success defined as complete or near complete resolution of postprocedure dysphagia and other related symptoms (regurgitation, halitosis, cough, hoarseness, weight loss, episodes of aspiration pneumonia).

研究概览

简要总结

The Zenker's or pharyngo-esophageal diverticulum is an acquired sac-like outpouching of the mucosa and submucosa layers located dorsally at the pharyngoesophageal junction through Killian's dehiscence. It is the most common type of oesophageal diverticula and typically occurs in middle-aged and elderly patients. Patients have a significantly reduced quality of life index and numerous complications.

Treatment is recommended for symptomatic patients and considering the aetiopathogenesis of the disease demands myotomy of the cricopharyngeal muscle. Myotomy may be pursued through either open surgical or endoscopic techniques.

There is a novel technique, called the peroral endoscopic myotomy (Z-POEM) for treatment of Zenker's diverticulum.

The ZIPPY trial designed as prospective, international, multicenter, double-blind, randomized study which will be carried out by experienced endoscopists. The aim of this study will be to evaluate the results of Zenker's diverticulum treatment using peroral endoscopic myotomy and to compare its efficacy and safety to flexible endoscopy septotomy. Patients at least 18 years old with symptomatic Zenker's diverticulum diagnosed on the basis of endoscopic and radiological examinations will be enrolled.

详细描述

Participants will be randomized into one of two groups: (I) Z-POEM, (II) flexible endoscopic septotomy. Patients with clinical failure will be offered other method of treatment and will be included to observational cohort. The study has been approved by a local bioethics committee

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Males and females who are 18 years of age and older and are able to comprehend instructions and follow the study procedures and are willing to sign an Informed Consent Form (ICF).
  • Patients with symptomatic Zenker's Diverticulum.
  • Confirmed diagnosis of Zenker's Diverticulum based on endoscopic and radiological examinations.
  • Size of Zenker's Diverticulum in the range of 1,5 to 4 cm on radiological examinations.

排除标准

  • Lack of written consent for participation in the study.
  • Size of Zenker's Diverticulum <1,5 cm or >4 cm on radiological examination.
  • Active cancer.
  • Esophageal stricture.
  • Eosinophilic esophagitis (EoE).
  • Pre-cancerous changes in the esophagus.
  • Previous surgical or endoscopic treatment of Zenker's Diverticulum.
  • Presence of chewing deficiencies and/or neurogenic dysphagia.
  • Presence of other esophageal motility disorders e.g. achalasia and/or spastic motility disorders.
  • Severe systemic diseases which are contraindication to general sedation.
  • Severe coagulopathy.
  • Pregnancy and breastfeeding.

结局指标

主要结局

Rate of short-term clinical success defined as complete or near complete resolution of postprocedure dysphagia and other related symptoms (regurgitation, halitosis, cough, hoarseness, weight loss, episodes of aspiration pneumonia).

时间窗: 3 Months

Rate of procedural technical success defined as completion of all steps of Z-POEM including complete cricopharyngeus myotomy.

时间窗: 3 Months

次要结局

  • Rate of long-term clinical success defined as lack of recurrence during 24 months follow-up(24 Months)
  • Assessment of clinical symptoms severity measured with the scale EAT-10(24 Months)
  • Assessment of clinical symptoms severity measured with the scale FOSS(24 Months)
  • Percentage of adverse events with graded severity.(24 Months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验